Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Q2 2009 results date notification - August 5, 2009

21st Jul 2009 13:00

Second quarter 2009 results date notification - August 5, 2009

July 20, 2009 - Shire plc , the global specialty biopharmaceutical company, will announce second quarter 2009 earnings on Wednesday August 5, 2009.

Results press release will be 12:00 BST / 07:00 EDT

issued at: Conference call time: 14:00 BST / 09:00 EDT

Angus Russell, Chief Executive Officer and Graham Hetherington, Chief Financial Officer will host the quarterly results presentation call at 14:00 BST/9:00 EDT.

The details of the conference call are as follows:

UK dial in: 0808 100 5150 or 01296 311 652 US dial in: 1 8662977327 or 1 7183541176

International dial in: +44 (0) 1296 311 652

Password/Conf ID: 515 749# Live Webcast:

http://www.shire.com/shire/InvestorRelations/index.jsp?tn=2

Replay:

A replay of the conference call will be available by phone for two weeks and onour website for 12 months. For further information; please visit our InvestorRelations' website. http://www.shire.com/shire/InvestorRelations/index.jsp?tn=2.

For further information please contact:

Investor Relations Souheil Salah (Rest of the World) +44 1256 894 160 Ricki Greenwood (North America) +1 484 595 8517 Notes to editorsSHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceuticalcompany that focuses on meeting the needs of the specialist physician. Shirefocuses its business on attention deficit hyperactivity disorder (ADHD), humangenetic therapies (HGT) and gastrointestinal (GI) diseases as well asopportunities in other therapeutic areas to the extent they arise throughacquisitions. Shire's in-licensing, merger and acquisition efforts are focusedon products in specialist markets with strong intellectual property protectionand global rights. Shire believes that a carefully selected and balancedportfolio of products with strategically aligned and relatively small-scalesales forces will deliver strong results.For further information on Shire, please visit the Company's website: www.shire.com. Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PXPress Release www.shire.com

vendor

Related Shares:

Shire
FTSE 100 Latest
Value8,774.65
Change-17.15